Gabapentin
Product Images NDC 50268-326

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50268-326). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 (326 13)

Label for Gabapentin Tablets, USP 800 mg by AvPAK. The label shows the product name, strength, dosage form, a quantity of 30 tablets (6 x 5 unit dose), and prescription use indication (Rx Only). It includes storage instructions, a barcode, the labeler's name and location (AvPAK, Pulaski, TN), and branding with the AvPAK logo.*

FDA Label Image

Chemical Structure (Gabapenin 01)

Chemical structure diagram of gabapentin showing a cyclohexane ring with aminomethyl and carboxymethyl side groups attached.*

FDA Label Image

Figure 1 (Gabapenin 02)

A line graph comparing mean pain scores over an 8-week period for placebo and Gabapentin 3,600 mg/day groups. The x-axis represents weeks, including a 4-week dose titration period followed by a 4-week fixed dose period, while the y-axis shows the mean pain score ranging from 0 to 10. Gabapentin group scores decrease over time compared to placebo group.*

FDA Label Image

Figure 2 (Gabapenin 03)

A line graph showing mean pain scores over time in weeks, comparing placebo with gabapentin at doses of 1,800 mg/day and 2,400 mg/day. The graph differentiates a 3-week dose titration period and a 4-week fixed dose period, with pain scores generally decreasing more for gabapentin groups than placebo.*

FDA Label Image

Figure 3 (Gabapenin 04)

A bar chart presenting results from two studies comparing placebo (PBO) with gabapentin (GBP) dosed at 1,800, 2,400, and 3,600 units. It shows percentage values on the y-axis ranging from 0% to 100%, with significant differences marked by p-values below the bars. Study 1 compares PBO (12%) with GBP 3,600 (29%), and Study 2 compares PBO (14%) with GBP 1,800 (32%) and GBP 2,400 (34%).*

FDA Label Image

Figure 4 (Gabapenin 05)

A scatter plot showing percentage difference on the y-axis and daily dose in mg on the x-axis. The plot compares results from three studies labeled a, b, and c, with data points at doses around 600, 900, 1200, and 1800 mg, illustrating differences for each study at these dose levels.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.